(ECT) |
| 0 (0%) 04-16 06:22 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 61.71 |
| Resistance 1: | 52.83 |
| Pivot price: | 50.47 |
| Support 1: | 50.16 |
| Support 2: | 48.51 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 15 Apr 2026
Major Clinical Trial Validates Efficacy and Safety of Innovative Brain Stimulation Therapy for Depression - Bioengineer.org
Wed, 15 Apr 2026
A new depression treatment may rival electroconvulsive therapy while avoiding one of its biggest drawbacks - Medical Xpress
Mon, 13 Apr 2026
Electroconvulsive Therapy for Depression: A Treatment Option to Support Mental Health - University of Utah Health
Mon, 16 Mar 2026
Successful bilateral electroconvulsive therapy for catatonia presenting with novel climbing behavior in an adolescent with CACNA1A pathogenic variant and autism spectrum disorder: a case report - Frontiers
Fri, 27 Feb 2026
Electroconvulsive Therapy Provides Hope for Treatment-Resistant Depression - Hackensack Meridian Health
Tue, 17 Feb 2026
Electroconvulsive Therapy during the COVID-19 Pandemic: Nationwide Data from Denmark - medRxiv
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
